Literature DB >> 30379690

Two cases of dolutegravir failure with R263K mutation.

Margarida Cardoso1, Teresa Baptista1, Isabel Diogo2, Maria João Aleixo3, Nuno Marques3, Kamal Mansinho1, Perpétua Gomes2,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30379690     DOI： 10.1097/QAD.0000000000001978

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  3 in total

1.  An Evolutionary Model-Based Approach To Quantify the Genetic Barrier to Drug Resistance in Fast-Evolving Viruses and Its Application to HIV-1 Subtypes and Integrase Inhibitors.

Authors:  Kristof Theys; Pieter J K Libin; Kristel Van Laethem; Ana B Abecasis
Journal:  Antimicrob Agents Chemother       Date:  2019-07-25       Impact factor: 5.191

2.  A systematic review of the genetic mechanisms of dolutegravir resistance.

Authors:  Soo-Yon Rhee; Philip M Grant; Philip L Tzou; Geoffrey Barrow; P Richard Harrigan; John P A Ioannidis; Robert W Shafer
Journal:  J Antimicrob Chemother       Date:  2019-11-01       Impact factor: 5.790

3.  Emergence of Resistance to Integrase Strand Transfer Inhibitors during Dolutegravir Containing Triple-Therapy in a Treatment-Experienced Patient with Pre-Existing M184V/I Mutation.

Authors:  Dominique L Braun; Thomas Scheier; Ulrich Ledermann; Markus Flepp; Karin J Metzner; Jürg Böni; Huldrych F Günthard
Journal:  Viruses       Date:  2020-11-19       Impact factor: 5.048
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.